MondegarAI
22NW, LP

Q1 2026 · 13F-HR

22NW, LPholdings as filed

Filed 2026-05-15 · accession 0001214659-26-006481

$145.9M
Reported value
16
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · 22NW, LP · Q1 2026

AI · grounded in 13F

22NW, LP closed its position in ANEB, reducing exposure by $84.76M. The fund established a new position in FOXF worth $11.16M and increased its holdings in NSP by 411.94%. Other exits included closing positions in MEC and MGTX.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
350060109FSTRFOSTER L B CO$29.8M20.4%1,067,186CommonSOLE
640268306NKTRNEKTAR THERAPEUTICS$20.2M13.9%281,115CommonSOLE
514766104LFCRLIFECORE BIOMEDICAL INC$18.9M12.9%1,254CommonSOLE
45778Q107NSPINSPERITY INC$13.3M9.14%493,000CommonSOLE
603170101MLYSMINERALYS THERAPEUTICS INC$12.0M8.25%444,325CommonSOLE
86183P102SRISTONERIDGE INC$11.9M8.17%2,466,975CommonSOLE
35138V102FOXFFOX FACTORY HLDG CORP$11.2M7.65%678,165CommonSOLE
230215105CULPCULP INC$5.1M3.49%1,859,061CommonSOLE
218683100CMTCORE MOLDING TECHNOLOGIES IN$5.0M3.42%222,738CommonSOLE
75901B107RGNXREGENXBIO INC$4.1M2.83%492,759CommonSOLE
904677200UFIUNIFI INC$3.0M2.09%852,455CommonSOLE
878155308TISITEAM INC$2.7M1.86%170,187CommonSOLE
76200L309RZLTREZOLUTE INC$2.5M1.72%820,653CommonSOLE
307675108FB1FARMER BROS CO$2.5M1.70%1,955,526CommonSOLE
28617K101ELDNELEDON PHARMACEUTICALS INC$2.0M1.34%636,364CommonSOLE
71742W103PFXPHENIXFIN CORP$1.7M1.15%43,115CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.